The CPHI & PMEC China 2026 exhibition, held from June 16–18, 2026, at the Shanghai New International Expo Centre, has officially concluded. Co-located with CPHI China, PMEC China 2026 hosted a line-up of over 3,600 exhibitors and more than 110,000 global attendees across a 240,000 m² exhibition area, solidifying its position as a must-attend event for the global pharmaceutical and nutraceutical community.
Over three days of intensive engagement, technical discussions, and global networking, Wellgreen welcomed a steady flow of partners and industry professionals at Booth E4B32, reinforcing its position as a trusted provider of integrated botanical, nutritional ingredient, and advanced liposomal delivery solutions.
From Exhibition Presence to Meaningful Global Collaboration
Throughout the event, Wellgreen engaged with industry professionals from Europe, North America, and the Asia-Pacific regions. Discussions centered on long-term cooperation, formulation development, supply chain reliability, and ingredient stability across diverse application areas.
The exhibition served as both a product showcase and a platform for building strategic partnerships, reflecting the increasing demand for stable, science-driven natural ingredients across multiple sectors-including nutraceuticals, functional foods, beverages, animal nutrition, and cosmetics.
Interest was particularly strong in both botanical extracts and advanced liposomal delivery systems, highlighting ongoing market shifts toward functional, bioavailable nutrition solutions. The clean-label movement continues to drive demand across the health industry, with the global clean-label ingredients market projected to grow at a CAGR of 6.5% and exceed USD 62.4 billion by 2030.
Wellgreen meeting with international partners at CPHI PMEC Shanghai 2026 natural ingredients exhibition
Visitors engaging with Wellgreen botanical and nutritional ingredient solutions at CPHI Shanghai 2026
Wellgreen team CPHI China 2026 meeting with global nutraceutical and functional food partners
Wellgreen botanical extracts yucca apple cider vinegar broccoli mushroom CPHI Shanghai 2026
Wellgreen CEO Mr Liu is discussing botanical extract formulations with visitors at CPHI Shanghai 2026
Wellgreen team discussing liposomal delivery system applications with visitors at CPHI PMEC China 2026
Wellgreen technical consultation on ingredient stability and formulation compatibility, CPHI China 2026
Wellgreen team CPHI China 2026 meeting with global nutraceutical and functional food partners
Wellgreen liposomal NMN glutathione vitamin C Omega-3 display CPHI China 2026
Market-Driven Product Engagement: Wellgreen's Featured Portfolio
Customer discussions at the booth consistently centered on application performance, formulation compatibility, and quality consistency across the following product categories:
- YuccaWell™ Yucca Extract – A natural saponin-rich ingredient widely used in functional food, feed, and animal nutrition applications. Known for its ammonia-reducing properties and natural surfactant activity, YuccaWell™ attracted strong interest from feed manufacturers and livestock nutrition specialists seeking clean-label alternatives for gut health and environmental management.
OacvWell™ Apple Cider Vinegar Powder
A versatile powder format offering the functional benefits of liquid apple cider vinegar with enhanced stability and handling convenience. Frequently used in digestive health, metabolic support, and weight management formulations. The powder format drew particular attention from supplement brands and functional beverage developers.
BrocWell™ Broccoli Extract
A standardized source of glucoraphanin and sulforaphane, recognized as a potent Nrf2 activator supporting cellular detoxification and antioxidant defense pathways. Interest came primarily from nutraceutical brands developing advanced cellular health and longevity-focused products.
- Mushroom Extracts – A range of functional polysaccharide-rich mushroom ingredients, including Lion's Mane, Reishi, and Cordyceps, targeting cognitive health, immune support, and adaptogenic wellness formulations. These products align with the growing consumer interest in functional mushrooms for daily wellness and performance.
- Liposomal Series – Including Liposomal NMN, Liposomal Glutathione, Liposomal Vitamin C, and Liposomal Omega-3, this product line generated the strongest engagement. The liposomal delivery platform addresses the bioavailability limitations of conventional supplement formats-a critical consideration for formulators developing premium nutraceuticals.
The global liposomal drug delivery systems market was valued at USD 6.70 billion in 2025 and is projected to reach USD 13.25 billion by 2032, at a CAGR of 10.23%. This growth trajectory reflects the accelerating industry shift toward advanced delivery technologies that enhance ingredient absorption and efficacy.
Rather than focusing on individual product promotion, discussions emphasized:
- Application compatibility and formulation performance
- Ingredient stability under various processing conditions
- Supply consistency for global distribution
- Technical support and co-development opportunities
- Regulatory compliance and documentation readiness
Manufacturing Strength Behind Product Reliability and Supply Confidence
Wellgreen's customer confidence is supported by its vertically integrated production and quality infrastructure. The company's 73,000 m² manufacturing facility operates at 5,000 tons annual capacity, supported by self-owned plantations ensuring raw material traceability and in-house laboratories for quality control and R&D.
All operations are certified under cGMP, ISO, HACCP, Kosher, and Halal standards, ensuring compliance with global regulatory requirements across North America, Europe, and Asia-Pacific markets.
This integrated supply chain model-from raw material sourcing through finished product delivery-provides the consistency and reliability that global partners require for large-scale commercial production
Global Infrastructure Supporting International Partnerships
Wellgreen continues to strengthen its international support system through:
- EmerWell Bio LLC, our U.S.-based R&D and commercial subsidiary located in San Diego, provides localized technical support, formulation consultation, and rapid sample response for North American partners. Learn more at emerwelllabs.com
- Overseas warehouse in the United States, enabling faster response times and reduced lead times for North American customers
- Regional offices in Australia and New Zealand, supporting the growing Asia-Pacific customer base
This global network enhances technical communication, supply efficiency, and customer responsiveness across key markets-enabling partners to bring products to market faster with greater confidence.
Leadership Insight
During the exhibition, Mr. Liu, CEO of Wellgreen, met with global partners and commented:
"CPHI China 2026 provided an excellent platform to connect with both new and existing partners across the nutraceutical, functional food, and feed industries. The technical discussions we had reinforce our commitment to quality consistency, operational reliability, and responsible growth in the natural ingredients sector. The strong interest in our liposomal delivery systems and botanical extracts confirms that our focus on science-driven, application-oriented solutions is aligned with the evolving needs of the global market."
Looking Ahead: Building on the Momentum
The exhibition has concluded, but discussions initiated during the event continue to progress, with ongoing follow-ups and collaboration opportunities across multiple regions and application areas.
Wellgreen looks forward to building on the momentum from CPHI & PMEC China 2026 and continuing to deliver scalable, reliable, and innovation-driven botanical and liposomal ingredient solutions to global partners. The company remains committed to advancing the science of natural ingredients and supporting partners in bringing effective, science-backed products to consumers worldwide.
Connect with Wellgreen
For technical support, product specifications, or collaboration inquiries, contact our team:
Email: liu@wellgreenxa.com
U.S. R&D Center: 6342 Ferris Square, San Diego, CA 92121
References
- CPHI & PMEC China 2026 Official Website. (2026). What's new at CPHI & PMEC China 2026 cphi.com.
- CPHI China 2026 Natural Products Zone. (2026). cphi-china.cn.
- Research and Markets. (2026). Liposomal & Lipid Nanoparticle Drug Delivery Systems Market – Global Forecast 2026-2032.
- Informa Markets. (2026). CPHI & PMEC China 2026 Exhibition Overview – 3,600+ exhibitors, 110,000+ attendees.
- Mordor Intelligence. (2026). Clean Label Ingredients Market Report – CAGR 6.5%, USD 62.4 billion by 2030.
- Global Market Insights. (2026). Nutraceutical Ingredients Market Report – USD 98.5 billion (2025) to USD 203.2 billion (2035).
- CPHI China 2026 Exhibition Data. (2026). 240,000 m² exhibition area, 3,600 exhibitors, 150+ countries.
